A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults with End-stage Kidney Disease on Hemodialysis with a Central Venous Catheter (Phase IIa)

Trial Identifier: D7480C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: December 2024
Primary Completion Date: October 2026
Study Completion Date: July 2027
Condition: Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Glendale, CA, US, 91206
US, CA Los Angeles, CA, US, 90027
US, CA Riverside, CA, US, 92503
US, CA Tarzana, CA, US, 91356
US, CA Victorville, CA, US, 92392
US, FL Coral Springs, FL, US, 33071
US, FL Tampa, FL, US, 33603
US, IA Iowa City, IA, US, 52242
US, IL Chicago, IL, US, 60643
US, MD Baltimore, MD, US, 21225
US, MI Pontiac, MI, US, 48341
US, MO Kansas City, MO, US, 64111
US, MS Tupelo, MS, US, 38801
US, NC Kinston, NC, US, 28504
US, NM Albuquerque, NM, US, 87109
US, NY Ridgewood, NY, US, 11385
US, PA Bethlehem, PA, US, 18017
US, TN Knoxville, TN, US, 37923
US, TX Beaumont, TX, US, 77706
US, TX San Antonio, TX, US, 78215